$
1.760
-0.08(-4.348%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
1.920
Open
1.860
VWAP
1.79
Vol
1.65M
Mkt Cap
92.40M
Low
1.710
Amount
2.95M
EV/EBITDA(TTM)
--
Total Shares
48.78M
EV
258.50M
EV/OCF(TTM)
123.86
P/S(TTM)
0.34
Cardlytics, Inc. is a provider of a digital advertising platform. Through the Cardlytics platform, its financial media network, marketers deliver advertising content to customers that allows them to earn rewards, which are funded with a portion of the fees it collects from marketers. It maintains the Cardlytics platform in both the United States and the United Kingdom. Cardlytics platform helps marketers find new customers that are active in their category but not shopping with them, or to grow their business with existing customers. Cardlytics platform provides its marketers with a scalable solution for driving customer loyalty and engagement, whereby Cardlytics handles everything from contracting with marketers and creating, managing and reporting the performance of their campaigns to attributing incentives to each of its partners customers. The Bridg platform is a customer data platform that utilizes POS data from its merchant data partners, including product-level purchase data.
Show More

Market Estimates

Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q1
FY2025Q2
FY2025Q3
64.02M
-8.07%
-0.267
+196.3%
67.33M
+0.4%
-0.163
+8.33%
77.79M
+5.12%
-0.098
-35%
Estimates Revision
The market is revising Downward the revenue expectations for Cardlytics, Inc. (CDLX) for FY2025, with the revenue forecasts being adjusted by -0.46% over the past three months. During the same period, the stock price has changed by -18.14%.
Revenue Estimates for FY2025
Revise Downward
down Image
-0.46%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-22.62%
In Past 3 Month
Stock Price
Go Down
down Image
-18.14%
In Past 3 Month
4 Analyst Rating
up Image
70.45% Upside
Wall Street analysts forecast CDLX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CDLX is 3.00 USD with a low forecast of 3.00 USD and a high forecast of 3.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
3 Hold
0 Sell
Hold
up Image
70.45% Upside
Current: 1.760
sliders
Low
3.00
Averages
3.00
High
3.00
Lake Street
Hold
downgrade
$3
2025-05-08
Reason
Lake Street lowered the firm's price target on Cardlytics to $2.50 from $3 and keeps a Hold rating on the shares. Cardlytics' solid Q1 and in line guidance is "encouraging," but the firm expects billings comps to be a headwind to growth the next two quarters, the analyst tells investors. Cardlytics "remains in the proving grounds, but there are encouraging signals Cardlytics could see a return to growth," added the analyst, who cites multiple compression in the space for the firm's lowered target.
Needham
Kyle Peterson
Hold
Reiterates
n/a
2025-03-13
Reason
Evercore ISI Group
Mark Mahaney
Hold
Maintains
$4 → $3
2025-03-13
Reason
Evercore ISI lowered the firm's price target on Cardlytics to $3 from $4 and keeps an In Line rating on the shares in the wake of a "Beat and Lower" quarter. The firm notes the company made continued progress in Q4 on campaign delivery issues and drove higher than expected pipeline wins, helping to offset anticipated spend reductions from key accounts in the restaurant and travel verticals. However, management's Q1 outlook was muted and commentary for the remainder of FY25 suggests to Evercore a more gradual billings rebound than it had previously expected. While the firm sees some green shoots and encouraging signs of progress here, it now views the path to sustainably positive adjusted EBITDA as a bit longer.
Lake Street
Jacob Stephan
Hold
Maintains
$5 → $3
2025-03-13
Reason
Lake Street lowered the firm's price target on Cardlytics to $3 from $5 and keeps a Hold rating on the shares. The firm believes the stock "remains in the proving grounds," but adds it is encouraged by emerging better ad delivery performance and supply side inventory. The firm cites broader multiple compression in the space for its price target cut.
Needham
Kyle Peterson
Hold
Reiterates
n/a
2025-01-17
Reason
Needham
Kyle Peterson
Hold
Reiterates
n/a
2024-11-07
Reason

Valuation Metrics

The current forward P/E ratio for Cardlytics Inc (CDLX.O) is -3.96, compared to its 5-year average forward P/E of -25.02. For a more detailed relative valuation and DCF analysis to assess Cardlytics Inc 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-25.02
Current PE
-3.96
Overvalued PE
52.66
Undervalued PE
-102.71

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-79.55
Current EV/EBITDA
-825.77
Overvalued EV/EBITDA
447.05
Undervalued EV/EBITDA
-606.15

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
4.44
Current PS
0.36
Overvalued PS
9.52
Undervalued PS
-0.64

Financials

Annual
Quarterly
FY2025Q1
YoY :
-8.45%
61.90M
Total Revenue
FY2025Q1
YoY :
+13.88%
-19.37M
Operating Profit
FY2025Q1
YoY :
-45.29%
-13.28M
Net Income after Tax
FY2025Q1
YoY :
-53.57%
-0.26
EPS - Diluted
FY2025Q1
YoY :
-51.67%
-10.81M
Free Cash Flow
FY2025Q1
YoY :
-7.28%
42.26
Gross Profit Margin - %
FY2025Q1
YoY :
-13.88%
-6.08
FCF Margin - %
FY2025Q1
YoY :
-40.24%
-21.46
Net Margin - %

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
34.4K
USD
3
3-6
Months
89.4K
USD
5
6-9
Months
760.4K
USD
11
0-12
Months
237.8K
USD
5
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 130.63% over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
45.1K
Volume
1
Bought
0-3
1
12.8K
Volume
Months
3-6
0
0.0
Volume
Months
6-9
1
5.5K
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

CDLX News & Events

Events Timeline

2025-08-06 (ET)
2025-08-06
17:41:11
Cardlytics sees Q3 revenue $52.2M-$58.2M, consensus $67.33M
select
2025-08-06
17:35:19
Cardlytics reports Q2 adjusted EPS (13c), consensus (16c)
select
2025-05-20 (ET)
2025-05-20
09:36:05
Cardlytics launches Cardlytics Rewards Platform
select
Sign Up For More Events

News

7.5
07-30Newsfilter
Hy-Vee's RedMedia Joins the Rippl Retail Media Network
3.5
07-15Newsfilter
Cardlytics Introduces New Customer Insights Dashboards Within the Cardlytics Insights Portal
5.0
05-20Newsfilter
Cardlytics Launches Cardlytics Rewards Platform and Expands Publisher Base Beyond Financial Institutions
Sign Up For More News

FAQ

arrow icon

What is Cardlytics Inc (CDLX) stock price today?

The current price of CDLX is 1.76 USD — it has decreased -4.35 % in the last trading day.

arrow icon

What is Cardlytics Inc (CDLX)'s business?

arrow icon

What is the price predicton of CDLX Stock?

arrow icon

What is Cardlytics Inc (CDLX)'s revenue for the last quarter?

arrow icon

What is Cardlytics Inc (CDLX)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Cardlytics Inc (CDLX)'s fundamentals?

arrow icon

How many employees does Cardlytics Inc (CDLX). have?

arrow icon

What is Cardlytics Inc (CDLX) market cap?